Adagrasib is a special kind of treatment that’s used for NSCLC patients who have a KRAS G12C mutation. It’s made to stop the action of these changed KRAS proteins. You can get it in 200 mg tablet form.
The recommended dosage for adagrasib is 600 mg taken twice daily, which can be taken with or without food. Each pack has 180 pills, and it lasts for about a month based on the daily amount you’re supposed to take. So, if you take 600 mg twice, that adds up to 1200 mg a day.
Adagrasib blocks the signals that tell lung cancer cells to grow. It’s like it’s trying to slow down the cancer’s spread.